重庆医学
重慶醫學
중경의학
CHONGQING MEDICAL JOURNAL
2013年
29期
3515-3517
,共3页
杨秀林%周厚荣%刘海健%杨娇荣%周霞
楊秀林%週厚榮%劉海健%楊嬌榮%週霞
양수림%주후영%류해건%양교영%주하
乌司他丁%心肺复苏术%细胞因子类%心脏功能试验
烏司他丁%心肺複囌術%細胞因子類%心髒功能試驗
오사타정%심폐복소술%세포인자류%심장공능시험
ulinastatin%cardiopulmonary resuscitation%cytokines%heart function tests
目的:探讨乌司他丁对心搏骤停-心肺复苏大鼠心脏的保护效应及改善心功能不全的机制。方法随机将20只SD大鼠分为3组:假手术组(不进行窒息及心肺复苏,仅进行麻醉和气管切开插管、血管穿刺;A组n=8);对照组(静脉注射生理盐水4mL·kg-1;B组n=6);考察组(乌司他丁5万U·kg-1+生理盐水3mL·kg-1,5万U配制成1mL;C组n=6);采用实验设计模型考察大鼠复苏前后实验设定时间段白细胞介素-12(IL-12)、心肌肌钙蛋白T(cTNT)、肿瘤坏死因子-α(TNF-α)、脑钠肽(BNP)、平均动脉压(MAP)、左室内压最大上升和下降速率(±LVdp.dt-1max)及左室舒张末压(LVEDP)的变化。结果与A组及复苏前比较,B、C组复苏后6hIL-12、cTNT、TNF-α、BNP、LVEDP等均有不同程度升高(P<0.01),而±LVdp.dt-1max值降低(P<0.01);与B组比较,C组复苏后6hIL-12、cTNT、TNF-α、BNP、LVED值低于B组,而±LVdp.dt-1max值高于B组(P<0.01);B组复苏后6hMAP值低于复苏前、同时间A组和C组(P<0.01)。结论乌司他丁可抑制炎症介质释放,减轻心搏骤停-心肺复苏实验大鼠心肌损伤,从而改善心搏骤停-心肺复苏实验大鼠心脏功能不全。
目的:探討烏司他丁對心搏驟停-心肺複囌大鼠心髒的保護效應及改善心功能不全的機製。方法隨機將20隻SD大鼠分為3組:假手術組(不進行窒息及心肺複囌,僅進行痳醉和氣管切開插管、血管穿刺;A組n=8);對照組(靜脈註射生理鹽水4mL·kg-1;B組n=6);攷察組(烏司他丁5萬U·kg-1+生理鹽水3mL·kg-1,5萬U配製成1mL;C組n=6);採用實驗設計模型攷察大鼠複囌前後實驗設定時間段白細胞介素-12(IL-12)、心肌肌鈣蛋白T(cTNT)、腫瘤壞死因子-α(TNF-α)、腦鈉肽(BNP)、平均動脈壓(MAP)、左室內壓最大上升和下降速率(±LVdp.dt-1max)及左室舒張末壓(LVEDP)的變化。結果與A組及複囌前比較,B、C組複囌後6hIL-12、cTNT、TNF-α、BNP、LVEDP等均有不同程度升高(P<0.01),而±LVdp.dt-1max值降低(P<0.01);與B組比較,C組複囌後6hIL-12、cTNT、TNF-α、BNP、LVED值低于B組,而±LVdp.dt-1max值高于B組(P<0.01);B組複囌後6hMAP值低于複囌前、同時間A組和C組(P<0.01)。結論烏司他丁可抑製炎癥介質釋放,減輕心搏驟停-心肺複囌實驗大鼠心肌損傷,從而改善心搏驟停-心肺複囌實驗大鼠心髒功能不全。
목적:탐토오사타정대심박취정-심폐복소대서심장적보호효응급개선심공능불전적궤제。방법수궤장20지SD대서분위3조:가수술조(불진행질식급심폐복소,부진행마취화기관절개삽관、혈관천자;A조n=8);대조조(정맥주사생리염수4mL·kg-1;B조n=6);고찰조(오사타정5만U·kg-1+생리염수3mL·kg-1,5만U배제성1mL;C조n=6);채용실험설계모형고찰대서복소전후실험설정시간단백세포개소-12(IL-12)、심기기개단백T(cTNT)、종류배사인자-α(TNF-α)、뇌납태(BNP)、평균동맥압(MAP)、좌실내압최대상승화하강속솔(±LVdp.dt-1max)급좌실서장말압(LVEDP)적변화。결과여A조급복소전비교,B、C조복소후6hIL-12、cTNT、TNF-α、BNP、LVEDP등균유불동정도승고(P<0.01),이±LVdp.dt-1max치강저(P<0.01);여B조비교,C조복소후6hIL-12、cTNT、TNF-α、BNP、LVED치저우B조,이±LVdp.dt-1max치고우B조(P<0.01);B조복소후6hMAP치저우복소전、동시간A조화C조(P<0.01)。결론오사타정가억제염증개질석방,감경심박취정-심폐복소실험대서심기손상,종이개선심박취정-심폐복소실험대서심장공능불전。
Objective To investigate the protective effects of ulinastatin on the hearts of rats with anoxia-induced cardiac arrest-cardiopulmonary resuscitation(CA-CPR) and the mechanism of improving cardiac dysfunction .Methods Twenty male Sprague Dawley(SD) rats were randomly divided into three experimental groups :sham operation group (group A ,n= 8 ,only anesthesia , tracheotomy tube and vascular puncture) ,control group(group B ,n= 6 ,normal saline 4 mL · kg -1 injected via vein) ,Ulinastatin treatment group(group C ,n=6 ulinastatin 50 000 U/kg+normal saline 3 mL · kg -1 injected via vein);Factors including mean arte-rial pressure(MAP) ,left ventricular end diastolic pressure(LVEDP) ,the maximum rising and falling rates of left ventricular deep pressure(± LVdp .dt-1max) ,brain natriuretic peptide(BNP) ,cardiac troponin T(cTNT) ,IL-12 and TNF-αwere observed at setting time before and after cardiopulmonary resuscitation in rats .Results Compared with those of the group A and before CA-CPR ,the concentrations of IL-12、cTNT、TNF-α、BNP、and LVEDP increased(P<0 .01)while ± LVdp .dt-1max decreased(P<0 .01) at 6 h after CA-CPR in group B ,C .Compared with those of group B ,the concentrations of IL-12、CTNT、TNF-α、BNP and LVEDP of 6 h after CA-CPR in group C were lower and ± LVdp .dt-1max was higher(P<0 .01) ,The concentrations of MAP of 6 h after CA-CPR in group B was lower Compared with that of group A ,C and before CA-CPR(P<0 .01) .Conclusion Ulinastatin can improve cardiac dysfunction by depressing mediators of inflammation and reducing myocardial injury .